R-1487

DB06518ExperimentalSmall molecule

Investigated for use/treatment in rheumatoid arthritis.

Mechanism: Pharmacologically active on Mitogen-activated protein kinase 14
Curator reviewed
Primary indication: Investigated for use/treatment in rheumatoid arthritis.Curator reviewed
Formula / weight: C₁₉H₁₈F₂N₄O₃ · 388.368 g/mol (avg)
Code names: R-1487

Resolves to

Compound

Structure

InChIKeyKKKRKRMVJRHDMG-UHFFFAOYSA-NSMILESCN1C(=O)C(OC2=CC=C(F)C=C2F)=CC2=C1N=C(NC1CCOCC1)N=C2

Targets

What you can answer from here — as of September 13, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with R-1487, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.